Advanced search
Publication Cover
Cell Cycle Volume 20, 2021 - Issue 24
Submit an article Journal homepage
506
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis

Binliang Wanga Department of Respiratory Disease, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China;b Department of Respiratory Disease, Taizhou First People’s Hospital, Taizhou, Zhejiang, ChinaView further author information
,
Yuanyuan Caic Department of Internal Medicine, Taizhou First People’s Hospital, Taizhou, Zhejiang, ChinaView further author information
,
Xiaobo Lib Department of Respiratory Disease, Taizhou First People’s Hospital, Taizhou, Zhejiang, ChinaView further author information
,
Yiming Kongb Department of Respiratory Disease, Taizhou First People’s Hospital, Taizhou, Zhejiang, ChinaView further author information
,
Haiwei Fub Department of Respiratory Disease, Taizhou First People’s Hospital, Taizhou, Zhejiang, ChinaView further author information
&
Jianying Zhoua Department of Respiratory Disease, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaCorrespondence[email protected]
View further author information
Pages 2607-2618 | Received 29 Mar 2021, Accepted 03 Nov 2021, Published online: 01 Dec 2021

References

  • Kuhn E, Morbini P, Cancellieri A, et al. Adenocarcinoma classification: patterns and prognosis. Pathologica. 2018;110(1):5–11.
  • Jarroux J, Morillon A, Pinskaya M. History, discovery, and classification of lncRNAs. Adv Exp Med Biol. 2017;1008:1–46.
  • Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–1109.
  • Weidle UH, Birzele F, Kollmorgen G, et al. Long Non-coding RNAs and their role in metastasis. Cancer Genomics Proteomics. 2017;14(3):143–160.
  • Yang J, Li C, Mudd A, et al. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer. Biosci Biotechnol Biochem. 2017;81(12):2301–2306.
  • Wang H, Huo X, Yang XR, et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017;16(1):136.
  • Zhang XT, Pan SX, Wang AH, et al. Long Non-Coding RNA (lncRNA) X-Inactive Specific Transcript (XIST) plays a critical role in predicting clinical prognosis and progression of colorectal cancer. Med Sci Monit. 2019;25:6429–6435.
  • Teimuri S, Hosseini A, Rezaenasab A, et al. Integrative Analysis of lncRNAs in Th17 cell lineage to discover new potential biomarkers and therapeutic targets in autoimmune diseases. Mol Ther Nucleic Acids. 2018;12:393–404.
  • Bouhlel MA, Lambert M, David-Cordonnier MH. Targeting Transcription Factor Binding to DNA by competing with DNA binders as an approach for controlling gene expression. Curr Top Med Chem. 2015;15(14):143–160.
  • Lambert M, Jambon S, and Depauw S, et al. Targeting transcription factors for cancer treatment. Molecules. 2018;23(6):1479 .
  • Jiang H, Li T, Qu Y, et al. Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression. Cancer Lett. 2018;425:78–87.
  • Peng Z, Wang J, Shan B, et al. The long noncoding RNA LINC00312 induces lung adenocarcinoma migration and vasculogenic mimicry through directly binding YBX1. Mol Cancer. 2018;17(1):167.
  • Rodriguez AC, Vahrenkamp JM, Berrett KC, et al. ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells. Cancer Res. 2020;80(6):1234–1245.
  • Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–718.
  • Zhang Y, Xu Y, Feng L, et al. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers. Oncotarget. 2016;7(39):64148–64167.
  • Yang XZ, Cheng TT, He QJ, et al. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Mol Cancer. 2018;17(1):126.
  • Li B, Mao R, Liu C, et al. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells. Life Sci. 2018;197:122–129.
  • Xiong DD, Li ZY, Liang L, et al. The LncRNA NEAT1 accelerates lung adenocarcinoma deterioration and binds to Mir-193a-3p as a competitive endogenous RNA. Cell Physiol Biochem. 2018;48(3):905–918.
  • Arocho A, Chen B, Ladanyi M, et al. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathology Am J Surg Pathol Part B. 2006;15(1):56–61
  • Wu W, Tan W, Ye S, et al. Analysis of the promoter region of the human miR-32 gene in colorectal cancer. Oncol Lett. 2019;17(4):3743–3750.
  • Smillie CL, Sirey T, Ponting CP. Complexities of post-transcriptional regulation and the modeling of ceRNA crosstalk. Crit Rev Biochem Mol Biol. 2018;53(3):231–245.
  • Wang Y, Fu J, Wang Z, et al. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis. Cancer Biomarkers. 2019;25(4):24–231.
  • Engreitz JM, Haines JE, Perez EM, et al. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 2016;539(7629):452–455.
  • Cheng T, Zhang Z, Cheng Y, et al. ETV4 promotes proliferation and invasion of lung adenocarcinoma by transcriptionally upregulating MSI2. Biochem Biophys Res Commun. 2019;516(1):278–284.
  • Wang Y, Ding X, Liu B, et al. ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally. Mol Carcinog. 2020;59(1):73–86.
  • Li DS, Ainiwaer JL, Sheyhiding I, et al. Identification of key long non-coding RNAs as competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 2016;20:2285–2295.
  • Chen C, Peng S, Li P, et al. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR. Mol Cell Biochem. 2020;475(1–2):15–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.